Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 939.50
-18.00 (-1.88%)
Nov 12, 2026, 3:29 PM IST
Anthem Biosciences Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Anthem Biosciences stock has a consensus rating of "Strong Buy" and an average price target of ₹974.25. The average 1-year stock price forecast is 3.70% higher than the current stock price, while the lowest is ₹850.00 (-9.53%) and the highest is ₹1,063 (+13.15%).
Price Target: ₹974.25 (+3.70%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Anthem Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains ₹1,000 | Buy | Maintains | ₹1,000 | +6.44% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
25.01B
from 21.29B
Increased by 17.47%
Revenue Next Year
30.17B
from 25.01B
Increased by 20.63%
EPS This Year
13.08
from 10.74
Increased by 21.84%
EPS Next Year
15.16
from 13.08
Increased by 15.90%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.